LYEL

Lyell Immunopharma (LYEL)

About Lyell Immunopharma (LYEL)

Lyell Immunopharma, Inc. operates as a holding company, which engages in the development of cell-based immunotherapies for human diseases. The company was founded by Richard D. Klausner, Stan Riddell, and Crystal Mackall in June 2018 and is headquartered in South San Francisco, CA.

Details

Daily high

$23.73

Daily low

$22.30

Price at open

$22.65

52 Week High

$45.00

52 Week Low

$7.65

Market cap

481.0M

Dividend yield

0.00%

Volume

124,585

Avg. volume

89,077

P/E ratio

-.99

Lyell Immunopharma News